These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 5099470)

  • 41. [Major hypertrichosis in an adult female secondary to porphyria cutanea tarda. Its evolution with chloroquine].
    Michel B; Guillot B; Guilhou JJ; Meynadier J
    Ann Dermatol Venereol; 1983; 110(4):361-3. PubMed ID: 6625460
    [No Abstract]   [Full Text] [Related]  

  • 42. [Porphyria cutanea tarda].
    Goerz G
    Fortschr Med; 1979 Sep; 97(36):1548-54. PubMed ID: 499964
    [No Abstract]   [Full Text] [Related]  

  • 43. [Catamnestic studies in porphyria cutanea tarda with special reference to therapy].
    Barth J; Petter O
    Z Gesamte Inn Med; 1971 Jan; 26(2):66-74. PubMed ID: 5560767
    [No Abstract]   [Full Text] [Related]  

  • 44. Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy.
    Wennersten G; Ros AM
    Acta Derm Venereol Suppl (Stockh); 1982; 100():119-23. PubMed ID: 6962628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chloroquine in the treatment of porphyria cutanea tarda.
    Kordac V; Papezová R; Semrádová M
    N Engl J Med; 1977 Apr; 296(16):949. PubMed ID: 846527
    [No Abstract]   [Full Text] [Related]  

  • 46. [Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)].
    Chlumský J; Dobiás J; Chlumská A; Malina L
    Cas Lek Cesk; 1977 Nov; 116(45):1404-6. PubMed ID: 603887
    [No Abstract]   [Full Text] [Related]  

  • 47. Metabolic alkalinization therapy in porphyria cutanea tarda.
    Perry HO; Mullanax MG; Wiegand SE
    Arch Dermatol; 1970 Oct; 102(4):359-67. PubMed ID: 5470946
    [No Abstract]   [Full Text] [Related]  

  • 48. Acquired porphyria cutanea tarda: two cases treated by repeated phlebotomies.
    Danby CW; Koval A; Wyllie J
    Can Med Assoc J; 1966 Jun; 94(26):1358-9. PubMed ID: 5940642
    [No Abstract]   [Full Text] [Related]  

  • 49. Porphyria cutanea tarda in association with hemosiderosis of the liver. Iron absorption studies and evaluation of therapy by phlebotomy.
    Strickland GT
    Am J Gastroenterol; 1968 Sep; 50(3):202-7. PubMed ID: 5677557
    [No Abstract]   [Full Text] [Related]  

  • 50. Phlebotomy for porphyria cutanea tarda.
    JAMA; 1969 Feb; 207(6):1142. PubMed ID: 5818250
    [No Abstract]   [Full Text] [Related]  

  • 51. [Results of bloodletting treatment in porphyria cutanea tarda].
    Schirren C; Strohmeyer G; Wehrmann R; Wiskemann A
    Dtsch Med Wochenschr; 1966 Jul; 91(30):1344-9. PubMed ID: 5940791
    [No Abstract]   [Full Text] [Related]  

  • 52. Porphyria cutanea tarda.
    Arch Dermatol; 1970 Sep; 102(3):346-7. PubMed ID: 5456029
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 54. Porphyria cutanea tarda and pregnancy.
    Goerz G; Hammer G
    Dermatologica; 1983 Jun; 166(6):316-8. PubMed ID: 6884554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A summary of twelve-year experience on the therapy of porphyria cutanea tarda (author's transl)].
    Resl V
    Cesk Dermatol; 1978; 53(5):336-43. PubMed ID: 729018
    [No Abstract]   [Full Text] [Related]  

  • 56. [Phlebotomy in porphyria cutanea tarda (author's transl)].
    Merino RA; Wolff C
    Rev Med Chil; 1979 Sep; 107(9):838-41. PubMed ID: 542750
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapy of porphyria cutanea tarda by serial phlebotomies].
    Malina L
    Cas Lek Cesk; 1971 Sep; 110(39):916-8. PubMed ID: 5098275
    [No Abstract]   [Full Text] [Related]  

  • 58. Five cases of porphyria cutanea tarda with mild cutaneous changes: evaluation of the efficacy of phlebotomy by the pattern analysis of urinary porphyrins.
    Nonaka S; Ohgami T; Murayama F; Yamashita K; Yoshida H
    J Dermatol; 1986 Jun; 13(3):196-202. PubMed ID: 3537046
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of therapy in acquired porphyria cutanea tarda.
    Hoo TT
    S Afr Med J; 1971 Sep; ():197-9. PubMed ID: 5150278
    [No Abstract]   [Full Text] [Related]  

  • 60. Porphyria cutanea tarda. A study of the effect of phlebotomy.
    Epstein JH; Redeker AG
    N Engl J Med; 1968 Dec; 279(24):1301-4. PubMed ID: 5697519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.